The objective of this study was to view the history and deep roots of medical cannabis and it’s use as a medicine. The study’s objective was to also look at and discuss the physiology and pharmacology of the ECS – the endocannabiniod system and to see whether or not medical cannabis and it’s chemical compounds, cannabiniods have therapeutic effects in fighting headaches and migraines.
Here is the full scientific article if you wish to download it.
The study discuses, in detail the origins of the cannabis plant. It details that cannabis, a plant genus is from the plant family known as Cannabaceae. 3 plants from the cannabis plant family are:
The study states that the history of cannabis had a prominent position in the medical world as a medicine. It is said that cannabis has been translated from Hindi literature as early as 1400‐2000 BC, but its medical use was better described in Indian Ayurvedic medicine.
However, in 1970, Dr. Roger O. Egeberg who was the assistant Secretary of Health, wrote a letter stating that cannabis should be a schedule 1 drug. Thus, due to the lack of therapeutic evidence, cannabis was made as a schedule 1 drug.
Later, cannabis was observed by the Federal Drug Administration (FDA) and had approved a synthetic version of one of the chemical compounds found in the cannabis plant – cannabinoid Δ9‐THC for medical purposes. This lead to an attempt to reclassify to Schedule 2 in 1988 which failed.
The editor of British Medical Journal, Richard Smith, supported cannabis and called for some legalization and decriminalization of the plant. The Journal of the American Medical Association also agreed with this state. Studies on cannabis have grown since, and in April 2014, the The Epilepsy Foundation expressed to the DEA that they should modify the restrictions on the cannabis plant in order to proceed with medical research.